N3C Domain Team: Gastroenterology and Hepatology (GI/Liver)

Mission

The Gastroenterology and Hepatology Domain Team aims to gain a better understanding of how SARS-Cov-2 infection affects patient populations with chronic gastrointestinal and liver diseases—including, but not limited to, inflammatory bowel diseases, diseases of the biliary tract, chronic hepatitis, cirrhosis, and gastrointestinal cancers. The initial research of this Domain Team will focus on the outcomes of SARS-CoV-2 infection in patients with cirrhosis and patients with chronic liver diseases.

Team meetings are held on the 3rd Monday of the month (beginning May 17th) at 10:00am PT/1:00pm ET. Please email n3c-dt-liver@googlegroups.com for meeting link.


Join the Team!

First Time Users: To get started with N3C and gain access to the N3C Data Enclave, please view the Researcher Essentials webpage.
For Questions or Comments: Please access the N3C Support Desk and click on "Request Domain Team Support".
Google Drive:
GI/Liver Drive
Google Group:
n3c-dt-liver@googlegroups.com
Slack Channel:
Join the Conversation

Leadership

Jin Ge, MD, MBA
University of California, San Francisco

To Cite the N3C: "The analyses described in this [publication/report/presentation] were conducted with data or tools accessed through the NCATS N3C Data Enclave https://covid.cd2h.org and N3C Attribution & Publication Policy v 1.2-2020-08-25b supported by NCATS Contract No. 75N95023D00001 and [insert additional funding agencies or sources and reference numbers as declared by the contributors in their form response above]. This research was possible because of the patients whose information is included within the data and the organizations (https://ncats.nih.gov/n3c/resources/data-contribution/data-transfer-agreement-signatories) and scientists who have contributed to the on-going development of this community resource [https://doi.org/10.1093/jamia/ocaa196]."

For publication submission information, please see the Publication Review Page

Sign up for the N3Connect Bulletin.